MedPath

Mindfulness Group-based Intervention for Early Psychosis

Not Applicable
Completed
Conditions
Schizophrenia
Psychotic Disorders
Interventions
Behavioral: Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Registration Number
NCT03143907
Lead Sponsor
Lawson Health Research Institute
Brief Summary

Recent research has suggested that mindfulness-based interventions (MBI) for psychosis may be effective in reducing the negative symptoms of schizophrenia (e.g., social withdrawal, lack of motivation) and the distress associated with psychotic symptoms (e.g., hearing voices) and could lead to improvements in functioning and quality of life. MBI research to date has primarily focused on studies of patients with chronic psychotic illness, yet relatively little is known about the use of MBIs for youth recovering from their first episode of psychosis. Results from recently published pilot studies appear promising in terms of the feasibility, acceptability, and potential clinical utility (e.g., improved psychological symptoms) of MBIs for the early psychosis population (Ashcroft et al., 2012; van der Valk et al., 2013; Khoury et al., 2015). The current project team has completed a pilot study at the Prevention and Early Intervention Program for Psychoses (PEPP) at London Health Sciences Centre (LHSC), wherein the "Mindfulness Ambassador Council" (MAC), a 12-week facilitated group intervention promoting mindfulness skills and the development of emotional and social competencies, was shown to be an effective, feasible, and acceptable means of treating youth in the early stages of psychotic illnesses. In follow up to the initial pilot study, the purpose of this study is to perform a multi-site Randomized Control Trial to determine the effectiveness of the MAC group intervention on reducing psychotic disorder symptomatology for transitional aged youth experiencing early psychosis. The main hypothesis, based on previous findings on the use of MBIs in psychotic disorders, including results from our initial pilot study at PEPP, is that people with early psychosis who participate in the MAC group intervention will experience improvement in mindfulness skills and affective symptoms compared to those receiving treatment as usual (TAU). Furthermore, we expect that people experiencing early psychosis who participate in MAC will have an improvement in their negative symptoms, quality of life, recovery (self-esteem, perceived recovery), perceived coping, assertiveness, social functioning, and cognitive skills, and a reduction in healthcare service utilization (e.g., emergency room visits, inpatient admissions/length of hospitalization).

Detailed Description

The purpose of this multi-site RCT is to determine the effectiveness of the MAC group intervention on reducing psychotic disorder symptomatology (primary outcome) as well as promoting quality of life, critical skills for recovery and decreasing mental health service utilization (secondary outcomes) for transitional aged youth (16-25 years old) experiencing early psychosis. This study is being run at five southern Ontario Early Psychosis Intervention (EPI) sites with Prevention and Early Intervention Program for Psychoses (PEPP) at London Health Sciences Centre (LHSC) being the lead site. Three of the larger sites (located in London, Kitchener-Waterloo, and Hamilton Ontario) are following the RCT design, while the two smaller sites (located in Chatham-Kent and Sarnia, Ontario) are participating in a pre-post design.

For the three RCT sites we aim to recruit 20-24 participants, and for the pre-post sites we aim to recruit 10 participants (total n=92 participants). Participants at the RCT sites will be randomized into Group-A (n = 12; immediate treatment intervention group) or Group-B (n = 12; delayed treatment intervention group). Group-A will receive the MAC intervention at the onset of the study, while Group-B will receive treatment as usual (TAU). Group-B will have the option of receiving the MAC intervention approximately 6 months after the onset of the study. At all times during this study, participants who are receiving the MAC intervention will also be able to continue receiving TAU. Both groups will be assessed with a battery of quantitative measures at baseline (T1), three months later (i.e., immediately post-MAC intervention) (T2), and again three months post-MAC intervention (T3). The measures include interview assessments of psychotic disorder symptoms, and self-report measures of affect, self-esteem, quality of life, coping strategies, assertiveness, social functioning, mindfulness and cognitive skills. In addition, healthcare utilization records for the 6 months preceding MAC intervention onset and for the 6 month duration of the study (3 month MAC intervention + 3 month post-MAC intervention follow-up period) will be collected. Researchers conducting symptom assessment interviews and data analysis will be blinded to the group membership of participants. For the two pre-post sites, all 10 participants will receive the MAC intervention immediately. All 10 participants will complete T1, T2, and T3 assessments and their healthcare utilization records will also be collected.

Based on the pilot study at PEPP-LHSC, and based on previous findings of Mindfulness Based Interventions for psychoses in the literature, we are expecting that participation in the MAC intervention will result in improvement in the following areas: psychotic symptomology (including affective symptoms), mindfulness skills, quality of life, measures of recovery (self-esteem, perceived recovery), perceived coping, assertiveness, social functioning, cognitive skills, and a reduction in healthcare service utilization (e.g., emergency room visits, inpatient admissions/length of hospitalization).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Participants must currently be in treatment for psychosis at one of the five Early Psychosis Intervention (EPI) study sites. In addition, participants must have been involved in the program for a period of less than 3 years, due to the focus of this study being on the treatment of early psychosis. Participants must be fluent in English, as determined by referring clinicians or researchers (in the case of advertisement referred participants) in order to meaningfully participate in the MAC intervention and complete the assessment tools.
Read More
Exclusion Criteria
  • Potential participants that show high levels of disorganized or disruptive behaviour (as determined by a cut off score of 4 or 5 on the Positive Formal Thought Disorder or Bizarre Behaviour items of the Scale for the Assessment of Positive Symptoms [SAPS]) such that they will not be able to meaningfully participate in the MAC intervention will be excluded from the study.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group-A - Immediate InterventionMindfulness Ambassador Council for Early Psychosis (MAC-EP)Immediate Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Group-B - Delayed InterventionMindfulness Ambassador Council for Early Psychosis (MAC-EP)6 month treatment as usual waitlist followed by Mindfulness Ambassador Council for Early Psychosis (MAC-EP)
Primary Outcome Measures
NameTimeMethod
Self-Evaluation of Negative Symptoms (SNS)Baseline, change from Baseline in SNS at 3 months, change from Baseline in SNS at 6 months

Self-report measure for the assessment of negative symptoms

Kentucky Inventory of Mindfulness SkillsBaseline, change from Baseline in KIMS at 3 months, change from Baseline in KIMS at 6 months

Self-report measure of mindfulness skills

Secondary Outcome Measures
NameTimeMethod
Rosenberg Self-Esteem Scale (RSES)Baseline, change from Baseline in RSES at 3 months, change from Baseline in RSES at 6 months

self-report measure of self-esteem

Profile of Mood States - Short Form (POMS-SF)Baseline, change from Baseline in POMS-SF at 3 months, change from Baseline in POMS-SF at 6 months

self-report measure of mood

Ways of Coping Questionnaire (WCQ)Baseline, change from Baseline in WCQ at 3 months, change from Baseline in WCQ at 6 months

self-report measure of ways to cope

Rathus Assertiveness Scale (RAS)Baseline, change from Baseline in RAS at 3 months, change from Baseline in RAS at 6 months

self-report measure of assertiveness

First-Episode Social Functioning Scale (FESFS)Baseline, change from Baseline in FESFS at 3 months, change from Baseline in FESFS at 6 months

self-report measure of social functioning

World Health Organization Quality of Life Scale - Brief version (WHOQOL-BREF)Baseline, change from Baseline in WHOQOL at 3 months, change from Baseline in WHOQOL at 6 months

self-report measure of quality of life

Cognitive Failures Questionnaire (CFQ)Baseline, change from Baseline in CFQ at 3 months, change from Baseline in CFQ at 6 months

self-report measure of cognitive failures

Kentucky Inventory of Mindfulness Skills (KIMS)Baseline, change from Baseline in KIMS at 3 months, change from Baseline in KIMS at 6 months

self-report measure of mindfulness skills

Health Care Utilization Records Post-InterventionUtilization at Baseline and during the 6 months following the mindfulness intervention

form to document participant health care utilization

Maryland Assessment of Recovery in People With Serious Mental Illness (MAR)Baseline, change from Baseline in MAR at 3 months, change from Baseline in MAR at 6 months

self-report measure of perceived self-recovery

Trial Locations

Locations (5)

Cleghorn Early Psychosis Intervention Clinic

🇨🇦

Hamilton, Ontario, Canada

Canadian Mental Health Association Chatham-Kent Health Alliance

🇨🇦

Chatham, Ontario, Canada

Canadian Mental Health Association Wellington-Waterloo

🇨🇦

Guelph, Ontario, Canada

Canadian Mental Health Association Lambton-Kent

🇨🇦

Sarnia, Ontario, Canada

Prevention and Early Intervention Program for Psychoses

🇨🇦

London, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath